RAAS-inhibitorSGLT2-inhibitorbeta-blockerMRAmineralocorticoid receptor antagonistheart failureHFrEFHFmrEFHFpEF
…a mineralocorticoid receptor antagonist (MRA), 445 (69.5%) on a RAAS-inhibitor, and 414 (64.7%) on a SGLT2-inhibitor respectively. Overall, 21…